Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99

Journal of Internal Medicine

Volumn 256, Issue 2, 2004, Pages 161-165

  Johansson, P ^a   Kutti, J ^a   Andreasson B ^a   Safai Kutti, S ^a   Vilen L ^a   Wedel, H ^b   Ridell, B ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

Author keywords

Essential thrombocythaemia; Idiopathic myelofibrosis; Incidence; Myeloproliferative disorders; Polycythaemia vera

Indexed keywords

ADULT; AGED; ARTICLE; AUTOANALYZER; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; PHILADELPHIA 1 CHROMOSOME; PHILADELPHIA CHROMOSOME NEGATIVE CELL; POLYCYTHEMIA VERA; POPULATION RESEARCH; PRIORITY JOURNAL; SAMPLE SIZE; SEX DIFFERENCE; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; PHILADELPHIA CHROMOSOME; POLYCYTHEMIA VERA; RETROSPECTIVE STUDIES; SWEDEN; THROMBOCYTOSIS;

EID: 3242886491     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01357.x     Document Type: Article

References (25)

1. Modan B. An epidemiological study on polycythemia vera. Blood 1965; 26: 657-67.
2. Modan B, Kallner H, Zemer D, Yoran C. A note on the increased risk of polycythemia vera in Jews. Blood 1971; 37: 172-6.
3. Silverstein MN, Lanier AP. Polycythemia vera, 1935-1969: an epidemiologic survey in Rochester, Minnesota. Mayo Clin Proc 1971; 46: 751-3.
4. Kurita S. Epidemiological studies of polycythemia vera in Japan (author's transi). Nippon Ketsueki Gakkai Zasshi 1974; 37: 793-5.
5. Dougan LE, Matthews ML, Armstrong BK. The effect of diagnostic review on the estimated incidence of lymphatic and hematopoietic neoplasms in Western Australia. Cancer 1981; 48: 866-72.
6. Prochazka AV, Markowe HL. The epidemiology of polycythaemia rubra vera in England and Wales 1968-1982. Br J Cancer 1986; 53: 59-64.
7. Berglund S, Zettervall O. Incidence of polycythemia vera in a defined population. Eur J Haematol 1992; 48: 20-6.
8. Chaiter Y, Brenner B, Aghai E, Tatarsky I. High incidence of myeloproliferative disorders in Ashkenazi Jews in northern Israel. Leuk Lymphoma 1992; 7: 251-5.
9. Ania BJ, Suman VJ, Sobell JL, Codd MB, Silverstein MN, Melton LJ III. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents. 1935-1989. Am J Hematol 1994; 47: 89-93.
10. Carli PM. Epidemiology of polycythemia vera in Côte d'Or (Burgundy). Nouv Rev Fr Hematol 1994; 36: 147-9.
11. Ridell B, Carneskog J, Wedel H et al. Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983-1992. Eur J Haematol 2000; 65: 267-71.
12. Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. Am J Hematol 1999; 61: 10-5.
13. Jensen MK, de Nully Brown P, Nielsen OJ, Hasselbalch HC. Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area. Eur J Haematol 2000; 65: 132-9.
14. Woodliff HJ, Dougan L. Myelofibrosis in Western Australia: an epidemiological study of 29 cases. Med J Aust 1976; 1: 523-5.
15. Statistical Year Book of Göteborg. Göteborg: Stadskansliet i Göteborg, 1983-1999.
16. Systematized Nomenclature of Medicine. Skookie, IL: College of American Pathologists, 1979.
17. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol 1986; 23: 132-43.
18. Pearson TC, Messinezy M. The diagnostic criteria of polycythaemia rubra vera. Leuk Lymphoma 1996; 22(Suppl. 1): 87-93.
19. International Committee for Standardization in Haematology. Recommended methods for measurement of red-cell and plasma volume. J Nucl Med 1980; 21: 793-800.
20. Carneskog J, Wadenvik H, Fjälling M, Kutti J. Assessment of spleen size using gamma camera scintigraphy in newly diagnosed patients with essential thrombocythaemia and polycythaemia vera. Eur J Haematol 1996; 56: 158-62.
21. Murphy S, Peterson P, Hand H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997; 34: 29-39.
22. Kutti J, Wadenvik H. Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis. Leuk Lymphoma 1996; 22(Suppl. 1): 41-5.
23. UICC. Cancer Incidence in Five Continents. A Technical Report, In: Doll R, Payne P, Water-house J, eds. Berlin: Springer Verlag. 1966.
24. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1991.
25. SAS Institute Inc. SAS Language Reference, Version 6.12, 1st edn. Cary, NC: SAS Institute Inc., 1990.